Phylinda S. Chan
Pfizer R&D UK Ltd Sandwich
Sandwich, ENG, United Kingdom
Sandwich, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Safety, Pharmacokinetics, and Dose Recommendations for Nirmatrelvir/Ritonavir in Individuals with Mild to Moderate COVID-19 and Severe Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: October 29, 2025
Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older.
Journal: Pediatrics
Published: August 20, 2025
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir.
Journal: Clinical pharmacokinetics
Published: December 11, 2023
Dosing recommendation of nirmatrelvir/ritonavir using an integrated population pharmacokinetic analysis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 28, 2023
Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation.
Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation.
Journal: Clinical pharmacology and therapeutics
Published: May 25, 2023
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: March 15, 2022
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials.
Journal: British journal of clinical pharmacology
Published: February 11, 2022
Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime-Avibactam in Pediatric Patients Aged 3 Months and Older.
Journal: Clinical pharmacology and therapeutics
Published: June 29, 2021
The use of extrapolation based on modeling and simulation to support high-dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft-tissue infections.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 29, 2021
Pregabalin Population Pharmacokinetic and Exposure-Response Analyses for Focal Onset Seizures in Children (4-16 years) and Adults, to Support Dose Recommendations in Children.
Journal: Clinical pharmacology and therapeutics
Published: August 11, 2020
Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion.
Journal: Clinical pharmacology in drug development
Published: May 11, 2020
Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis.
Journal: The Pediatric infectious disease journal
Published: February 25, 2020
Last Updated: 09/26/2026